Skip to main content

Table 4 Lung function and allergic airway inflammation

From: A feasibility study to assess Imbrasia belina (mopane worm) sensitisation and related respiratory health outcomes in a rural community in Gwanda district, Zimbabwe

Outcome variables

Sensitised to mopane worm (n = 9)

Not sensitised to mopane worm (n = 8)

Total (n = 17)

Geometric mean (95% CI)b

 FVC (L)

2.95 (2.33–3.75)

2.35 (2.02–2.75)

2.65 (2.3–3.06)

 FVC % predicted

81.23 (67.63–97.56)

75.39 (65.2–87.18)

78.06 (70.55–86.38)

 FEV1 (L)

2.46 (1.88–3.22)

2.08 (1.63–2.66)

2.27 (1.92–2.69)

 FEV1 % predicted

84.37 (67.99–104.71)

83.4 (68.68–101.29)

83.85 (74.05–94.96)

 FEF25–75% (L/s)

2.62 (1.79–3.85)

2.49 (1.55–3.98)

2.56 (1.96–3.33)

 FEF25–75 % predicted

101.36 (54.47–188.62)

90.82 (59.72–138.13)

95.95 (69.14–133.15)

 FEV1/FVC

0.85 (0.80–0.90)

0.88 (0.78–0.98)

0.86 (0.82–0.91)

 FEV1/FVC % predicted

95.73 (84.34–108.66)

110.58 (98.41–124.26)

102.45 (94.07–111.59)

 FeNO (ppb)

16.4 (5.25–51.23)

26.23 (8.03–85.69)

21.19 (10.7–41.94)

n (%)c

 Elevated FeNO (> 25 ppb) (total n = 11)

2 (40)

3 (50)

5 (45)

 Abnormal FVC (< 80% Pred) (total n = 15)

3 (43)

5 (63)

8 (53)

 Abnormal FEV1 (< 80% Pred) (total n = 15)

4 (57)

2 (25)

6 (40)

 Abnormal FEF25–75% (< 80% Pred) (total n = 16)

3 (38)

2 (25)

5 (31)

  1. FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, FEF25–75% forced expiratory flow at 25 to 75% of forced vital capacity, FENO fractional exhaled nitric oxide
  2. bNo differences between the two sensitisation groups using the two-sample Wilcoxon rank-sum (Mann-Whitney) test
  3. cNo significant differences between the two sensitisation groups using Fisher’s exact test